Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Dianthus Therapeutics (DNTH) Receivables - Other (2018 - 2024)

Dianthus Therapeutics has reported Receivables - Other over the past 5 years, most recently at $807000.0 for Q4 2024.

  • Quarterly results put Receivables - Other at $807000.0 for Q4 2024, up 303.5% from a year ago — trailing twelve months through Dec 2024 was $807000.0 (up 303.5% YoY), and the annual figure for FY2024 was $807000.0, up 303.5%.
  • Receivables - Other for Q4 2024 was $807000.0 at Dianthus Therapeutics, down from $1.3 million in the prior quarter.
  • Over the last five years, Receivables - Other for DNTH hit a ceiling of $1.3 million in Q3 2024 and a floor of $200000.0 in Q4 2023.
  • Median Receivables - Other over the past 3 years was $800000.0 (2024), compared with a mean of $703714.3.
  • Biggest five-year swings in Receivables - Other: crashed 77.78% in 2023 and later surged 303.5% in 2024.
  • Dianthus Therapeutics' Receivables - Other stood at $900000.0 in 2022, then crashed by 77.78% to $200000.0 in 2023, then surged by 303.5% to $807000.0 in 2024.
  • The last three reported values for Receivables - Other were $807000.0 (Q4 2024), $1.3 million (Q3 2024), and $800000.0 (Q2 2024) per Business Quant data.